Genasense News
Most Popular Genasense Story
In survival mode, Genta hunts for funds
NJ Biz examines Genta, which has gone into survival mode as it seeks a way to gain FDA approval of its lead cancer therapy, Genasense. The FDA turned thumb's down on the therapy in 2004, and the... Read more...
Latest Headlines
- April 15, 2008
- January 14, 2008
- December 14, 2006
- October 29, 2006
- September 6, 2006
- September 5, 2006
- February 14, 2006
- September 18, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
